Showing results (61-70 of 325) with videos related to
Sort By:
Pageof 33
Vaccine|December 28, 2007
Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategiesWibke Bayer, Simone Schimmer, Dennis Hoffmann, et al.Journal of Virology|March 16, 2006
Effects of type I interferons on Friend retrovirus infectionNicole Gerlach, Simone Schimmer, Siegfried Weiss, et al.Plos One|December 19, 2013
Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infectionInga Ohs, Sonja Windmann, Oliver Wildner, et al.Plos Pathogens|October 16, 2020
Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 PathogenesisKejun Guo, Guannan Shen, Jon Kibbie, et al.Proceedings of the National Academy of Sciences of the United States of America|August 7, 2004
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infectionRonald J Messer, Ulf Dittmer, Karin E Peterson, et al.Journal of Medical Virology|September 4, 2020
Common respiratory viral infections: Bilateral versus unilateral bronchoalveolar lavage versus endotracheal aspirationOlympia E Anastasiou, Fotis Theodoropoulos, Christian Taube, et al.Journal of Virology|August 31, 2012
Modification of one epitope-flanking amino acid allows for the induction of friend retrovirus-specific CD8+ T cells by Adenovirus-based immunizationPhilipp Gödel, Sonja Windmann, Kirsten K Dietze, et al.Viral Immunology|April 22, 2020
Inhibition of IL-2 or NF-κB Subunit c-Rel-Dependent Signaling Inhibits Expansion of Regulatory T Cells During Acute Friend Retrovirus InfectionJean Alexander Ross, Anna Malyshkina, Lucas Otto, et al.Viral Immunology|April 2, 2016
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T CellsJara J Joedicke, Miriam Dirks, Stefan Esser, et al.The Journal of General Virology|November 22, 2005
Effective treatment of retrovirus-induced suppression of antibody responses with CpG oligodeoxynucleotidesAnke R M Kraft, Tanja Arndt, Kim J Hasenkrug, et al.Pageof 33